High-grade gliomas are an aggressive and invasive malignancy which are susceptible to
treatment resistance due to heterogeneity in intratumoral properties such as cell proliferation …

Glioblastoma multiforme (GBM) is the most malignant form of primary brain tumors known as
gliomas. They proliferate and invade extensively and yield short life expectancies despite …

Simple Summary Radiomics and radiogenomics offer new insight into high-grade glioma
biology, as well as into glioma behavior in response to standard therapies. In this article, we …

Glioblastoma (GBM) is a highly invasive brain tumor, whose cells infiltrate surrounding
normal brain tissue beyond the lesion outlines visible in the current medical scans. These …

Accurate clinical assessment of a patient's response to treatment for glioblastoma multiforme
(GBM), the most malignant type of primary brain tumor, is undermined by the wide patient-to …

Purpose Glioblastomas, lethal primary brain tumors, are known for their heterogeneity and
invasiveness. A growing body of literature has been developed demonstrating the clinical …

AIM To investigate machine learning based models combining clinical, radiomic, and
molecular information to distinguish between early true progression (tPD) and …

Background Intra-and inter-tumoral heterogeneity in growth dynamics and vascularity
influence tumor response to radiation therapy. Quantitative imaging techniques capture …

Background The inability of structural MRI to accurately measure tumor response to therapy
complicates care management for patients with gliomas. The purpose of this study was to …

Purpose To evaluate whether radiomic feature–based magnetic resonance (MR) imaging
signatures allow prediction of survival and stratification of patients with newly diagnosed …